optical genome mapping to detect abnormalities in aml
Published 1 month ago • 48 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
4:59
using optical genome mapping to characterize chromoanagenesis & tp53 mutations in patients with mds
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
1:13
cytometry versus morphology in the monitoring of aml
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:46
application of molecular genetic testing in aml
-
1:02
the impact of sequencing in aml
-
51:12
new technologies in glaucoma: ubm
-
24:37
bionano genome imaging
-
28:19
diagnosis: morphology, flow cytometry, cytogenetics, molecular testing, and risk-stratification
-
2:43
diagnostic tools for aml
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
0:52
genomic profiling at diagnosis of myeloid neoplasms
-
2:22
molecular mrd detection in aml
-
15:09
bionano optical genome mapping to decipher genomic structure variations in acute leukemias
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
4:42
a practical approach to the classification of mds
-
2:00
mrd detection with ngs for aml: a new era of diagnostics
-
57:08
optical genome mapping: unrivaled sv detection for cancer research and precision medicine
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:37
the importance of genomic testing in the diagnosis of cll
-
11:55
adoption of optical genome mapping in clinical cancer cytogenetic laboratory: a stepwise approach
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml